Cancer immunotherapy - PDFSEARCH.IO - Document Search Engine

Cancer immunotherapy
Results: 490

#	Item
281	On June 15, 2010, the NIH Recombinant DNA Advisory Committee (RAC) convened a symposium titled Gene-Modified T cells: Challenges in Clinical Trial Design Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-08 12:28:34 Cytokines Immune system T cells Cancer treatments Chimeric antigen receptor Immunology Cancer immunotherapy Immunotherapy Interleukin 2 Biology Medicine Anatomy
282	T Cell Immunotherapy - Optimizing Trial Design Office of Biotechnology Activities September 10, 2013 Overview Steven A. Rosenberg, M.D., Ph.D. Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-13 09:37:02 Immunology Cancer treatments Lymphoma Immunotherapy B-cell chronic lymphocytic leukemia Melanoma Cancer immunotherapy Chimeric antigen receptor Lymphocyte Medicine Immune system T cells
283	T Cell Immunotherapy for Cancer Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-08 13:16:43 Anatomy Immunology CD4 Chimeric antigen receptor Immunotherapy Antigen T-cell receptor CD8 CD25 Biology T cells Immune system
284	T Cell ImmunotherapyOptimizing Trial Design Session I Current Status of Cancer Immunotherapy: Trials, Results, and Challenges Investigator: Helen Heslop Institution: Baylor College of Medicine Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-09 16:15:27 Biology Chimeric antigen receptor CD3 Cancer immunotherapy Lymphocyte Immunotherapy T-cell receptor CD28 T cells Immune system Anatomy
285	Immune cells get cancer-fighting boost from nanomaterials Add to Reading List Source URL: phys.org Language: English - Date: 2014-11-28 04:17:22 Immunology Cancer treatments Cytokines T cells Immunotherapy Cancer immunotherapy Interleukin Carbon nanotube Carbon nanotubes in medicine Medicine Biology Immune system
286	VGX-3100: Induction of Potent Immune Responses in Post-LEEP CIN 2/3 Following Immunotherapy with HPV 16 & 18 Syncon™ DNA Vaccines Niranjan Y. Sardesai, Ph.D. Sr. Vice President, Research & Development Add to Reading List Source URL: www.immunome.org Language: English - Date: 2012-09-05 04:57:28 Vaccines Gynaecological cancer Vaccination Sexually transmitted diseases and infections HPV vaccine Human papillomavirus Cervical cancer DNA vaccination HPV-positive oropharyngeal cancer Papillomavirus Medicine Biology
287	Human Papillomavirus Immunotherapy and the Vaccine Exemption Under NIH Guidelines Recombinant DNA Advisory Committee Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-14 15:15:12 Microbiology HPV vaccine Human papillomavirus Cervical intraepithelial neoplasia Cervical cancer Vaccine Papillomaviridae Cervix HspE7 Papillomavirus Medicine Biology
288	T Cell ImmunotherapyOptimizing Trial Design Session I Current Status of Cancer Immunotherapy: Trials, Results, and Challenges Investigator: Helen Heslop Institution: Baylor College of Medicine Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-13 09:31:49 Biology Chimeric antigen receptor CD3 Cancer immunotherapy Lymphocyte Immunotherapy T-cell receptor CD28 T cells Immune system Anatomy
289	T Cell Immunotherapy - Optimizing Trial Design Office of Biotechnology Activities September 10, 2013 Host preparation Steven A. Rosenberg, M.D., Ph.D. Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-13 09:41:36 Radiobiology Cancer treatments Immunotherapy Steven Rosenberg Influenza Regulatory T cell Cyclophosphamide Radiation therapy Cell transfer therapy Medicine T cells Immunology
290	T Cell ImmunotherapyOptimizing Trial Design Session I Current Status of Cancer Immunotherapy: Trials, Results, and Challenges Richard P Junghans, PhD, MD Roger Williams Medical Center Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-13 09:36:10 Molecular biology Prostate cancer Retrovirus Prostate-specific membrane antigen Immunotherapy Cancer immunotherapy Neuroblastoma Lentivirus Medicine Oncology Immune system

UPDATE